Corrigendum to "Dihydroartemisin inhibits glioma invasiveness via a ROS to P53 to β-catenin signaling" [Pharmacol. Res. 119 (2017) 72–88]. (November 2021)

Record Type:: Journal Article
Title:: Corrigendum to "Dihydroartemisin inhibits glioma invasiveness via a ROS to P53 to β-catenin signaling" [Pharmacol. Res. 119 (2017) 72–88]. (November 2021)
Main Title:: Corrigendum to "Dihydroartemisin inhibits glioma invasiveness via a ROS to P53 to β-catenin signaling" [Pharmacol. Res. 119 (2017) 72–88]
Authors:: Que, Zhongyou
Wang, Ping
Hu, Yi
Xue, Yixue
Liu, Xiaobai
Qu, Chengbin
Ma, Jun
Liu, Yunhui
Abstract:
Is Part Of:: Pharmacological research. Volume 173(2021)
Journal:: Pharmacological research
Issue:: Volume 173(2021)
Issue Display:: Volume 173, Issue 2021 (2021)
Year:: 2021
Volume:: 173
Issue:: 2021
Issue Sort Value:: 2021-0173-2021-0000
Page Start:
Page End:
Publication Date:: 2021-11
Subjects:: Pharmacology -- Periodicals
Pharmacology -- Periodicals
Research -- Periodicals
Médicaments -- Recherche -- Périodiques
Pharmacologie -- Périodiques
615.105
Journal URLs:: http://www.sciencedirect.com/science/journal/10436618 ↗
http://www.elsevier.com/journals ↗
DOI:: 10.1016/j.phrs.2021.105908 ↗
Languages:: English
ISSNs:: 1043-6618
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - 6446.550000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 19614.xml